Analysis of Biomarkers From Patients With Chorioretinal Diseases

Launched by KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL · Dec 31, 2013

Keywords

ClinConnect Summary

This clinical trial is looking at the levels of certain biological markers in the eyes of patients with chorioretinal diseases, which are conditions that affect the retina and can lead to vision problems. Specifically, the study focuses on patients with diabetic retinopathy, age-related macular degeneration (both dry and wet types), and other retinal diseases. Researchers hope to learn more about these markers to improve understanding and treatment of these conditions.

If you're over 20 years old and have been experiencing vision difficulties that require eye treatment due to these specific eye diseases, you may be eligible to participate. The trial is currently recruiting participants, including those needing cataract surgery or other eye procedures. If you join, you will provide a sample of fluid from your eye, helping researchers gather important information. It’s important to note that if you’ve had recent eye infections, trauma, or specific treatments, you may not be able to participate. This study aims to enhance the knowledge of eye diseases and improve future treatments for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age over 20 years
• • patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
• • patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
• • control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
• Exclusion Criteria:
• • under the age of 20 years
• • patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
• • patients that did not signed the informed consent of the trial
• • patients with intraocular inflammations or infections that requiring any pharmaceutical agent
• • patients with recent ocular trauma